Oncology Coverage & Treatment: From the Front Lines to Wall Street belongs in serious BCBA study because it shapes whether behavior-analytic decisions stay useful once they leave a clean training example and enter clinical documentation, payer communication, supervision records, and leadership review. In Oncology Coverage & Treatment: From the Front Lines to Wall Street, for this course, the practical stakes show up in service continuity, accurate reporting, and defensible clinical decisions, not in abstract discussion alone.
Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →The panel will discuss on-the-ground cancer care paradigms, to investor and Wall Street perspectives, with an increasingly challenging policy backdrop. Value Based Care has long been thematic and aspirational, but where are we? With drug shortages and health insurance networks and prior authorizations, oncology providers face headwinds. Recent FDA restructuring and new government leadership will evaluate exciting medicines in development, as drug pricing pressure continues to irk Congress. Medicare IRA drug negotiation chugs on, with the next round of prices (for 2027) released before Thanksgiving (oncolytics included). Most Favored Nation and Tariff threats persist, as the Administration moves to strike deals with manufacturers.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Ipsita Smolinski is a veteran advisor on healthcare regulatory and legislative issues with over 20 years of experience in healthcare policy and economic analysis.As the Managing Director of Capitol Street, she advises clients on key trends and major actions coming out of Washington, D.C., as well as at the state, court and stakeholder levels.Smolinski holds a faculty appointment at the Johns Hopkins University Carey Business School where she teaches coursework in Healthcare Economics and Healthcare Finance. She also holds a faculty appointment at the Georgetown University where she teaches coursework in the Department of Health Policy & Management. Prior to launching Capitol Street in 2009, Smolinski was the Senior Equity Research Analyst for Healthcare Policy at J.P.Morgan. Before joining J.P.Morgan, Smolinski advised clients on health policy and trends at Citigroup and Bear Stearns. Earlier in her career, she spent several years as a healthcare management consultant at the Lewin Group, a Washington-based firm specializing in managed care and healthcare payment policy, and worked at both Pfizer and the Centers for Disease Control (CDC).Smolinski holds an MBA and a Masters in Public Health (MPH) from Columbia University and received her BA from the Johns Hopkins University in Baltimore, MD.
Dig into the research behind this topic — plain-English summaries written for BCBAs.
252 research articles with practitioner takeaways
224 research articles with practitioner takeaways
174 research articles with practitioner takeaways
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.